Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Cranfield University
- ; Newcastle University
- University of Nottingham
- University of Sheffield
- ; Swansea University
- Loughborough University;
- The University of Manchester;
- University of Cambridge
- University of East Anglia;
- ; Brunel University London
- Durham University;
- Harper Adams University
- The University of Edinburgh;
- University of East Anglia
- University of Newcastle
- University of Warwick;
- 6 more »
- « less
-
Field
-
to rare disease trials. This PhD studentship is part of LifeArc ARDT, a UK-wide £12m partnership between Newcastle, Birmingham, and Belfast to accelerate rare disease trials. Students will receive training
-
suggest hypotheses for therapeutic targeting. This PhD studentship is part of the LifeArc ARDT, a UK-wide £12m partnership between Newcastle, Birmingham, and Belfast to accelerate rare disease trials
-
in genomic medicine, diagnostic innovation or precision healthcare. This studentship is part of the LifeArc ARDT, a UK-wide £12m partnership between Newcastle, Birmingham, and Belfast to accelerate
-
validated surface functionalisation methods that significantly improve metascintillator performance, accelerating the development of advanced radiation detectors for ToF-PET and enhancing early cancer
-
conditions. This will accelerate the development and qualification of more resilient materials and coatings, contributing directly to the advancement of sustainable fusion energy. The techniques developed may
-
, for example, PM10 which is generally caused by acceleration and deceleration of road vehicles and is proportional to vehicle weight may increase due to the transition to electric cars, which are typically
-
. By integrating academic learning with industrial practice, graduates will be uniquely prepared to drive and accelerate aviation's decarbonization across various sectors, including industry, academia
-
to greatly accelerate bioactive molecule discovery and significantly reduce costs in drug discovery, enabling new drug targets that are currently economically unfeasible such as in rare and poverty-related
-
the electricity generation mix continues to grow. Installed capacity in the UK in 2020 was 13.4 GW and is expected to increase to 40 GW by 2030. Accelerating the adoption of solar energy will present significant
-
developing these systems, and will accelerating the supply of AI machine learning controlled machinery to farmers unlocking all of the benefits described in the first paragraph. Objective: Achieve both